Skip to main content
Log in

Loss of hip bone mineral density over time is associated with spine and hip fracture incidence in osteoporotic postmenopausal women

  • LOCOMOTOR DISEASES
  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

Abstract

The objective of the study assess the relationship between bone mineral density (BMD) loss over time and fracture incidence in postmenopausal women. This is a posthoc analysis that includes women from the placebo group of two large randomized controlled trials having assessed the efficacy of a new anti-osteoporotic drug. BMD was assessed every 6 months during 3 years at the lumbar spine, the femoral neck and the total proximal femur. Vertebral fractures were assessed using a semiquantitative method. Hip fractures were based on written documentation. All patients received calcium and vitamin D. In the present study that included 1,775 patients (with complete data at baseline and after 3 years), the logistic regression analysis, adjusted for covariates, showed that 3-year change in lumbar BMD was not statistically associated with the new vertebral fractures after 3 years. However, femoral neck and total proximal femur BMD changes was statistically correlated with the incidence of new vertebral fractures (P < 0.001). When considering change in BMD after the first year of follow-up, a decrease in total proximal femur BMD was statistically associated with an increase in the incidence of new vertebral fractures during the last 2 years of follow-up (P = 0.048). The 3-year change in femoral neck and total proximal BMD was statistically correlated with the incidence of hip and fragility fracture after 3 years (all P < 0.001). In this elderly osteoporotic population receiving calcium and vitamin D, a decrease in hip BMD after 1 or 3 year of follow-up, is associated with an increased risk of fracture incidence. However, spine BMD changes do not influence vertebral fracture incidence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Cummings SR, Black DM, Nevitt MC, Browner W, Cauley J, Ensrud K, et al. Bone density at various sites for prediction of hip fractures. The study of Osteoporotic Fractures Research Group. Lancet. 1993;341(8837):72–5.

    Article  CAS  PubMed  Google Scholar 

  2. Melton LJIII, Atkinson EJ, O’Fallon WM, Wahner HW, Riggs BL. Long-term fracture prediction by bone mineral assessed at different skeletal sites. J Bone Miner Res. 1993;8(10):1227–33.

    Article  PubMed  Google Scholar 

  3. Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ. 1996;312(7041):1254–9.

    CAS  PubMed  Google Scholar 

  4. Nordin BE, Cleghorn DB, Chatterton BE, Morris HA, Need AG. A 5-year longitudinal study of forearm bone mass in 307 postmenopausal women. J Bone Miner Res. 1993;8(12):1427–32.

    CAS  PubMed  Google Scholar 

  5. Hansen MA, Overgaard K, Riis BJ, Christiansen C. Role of peak bone mass and bone loss in postmenopausal osteoporosis: 12 year study. BMJ. 1991;303(6808):961–4.

    Article  CAS  PubMed  Google Scholar 

  6. Riis BJ, Hansen MA, Jensen AM, Overgaard K, Christiansen C. Low bone mass and fast rate of bone loss at menopause: equal risk factors for future fracture: a 15-year follow-up study. Bone. 1996;19(1):9–12.

    Article  CAS  PubMed  Google Scholar 

  7. Gnudi S, Malavolta N, Lisi L, Ripamonti C. Bone mineral density and bone loss measured at the radius to predict the risk of nonspinal osteoporotic fracture. J Bone Miner Res. 2001;16(6):1130–5.

    Article  CAS  PubMed  Google Scholar 

  8. Sornay-Rendu E, Munoz F, Duboeuf F, Delmas PD. Rate of forearm bone loss is associated with an increased risk of fracture independently of bone mass in postmenopausal women: the OFELY study. J Bone Miner Res. 2005;20(11):1929–35.

    Article  PubMed  Google Scholar 

  9. Hillier TA, Stone KL, Bauer DC, Rizzo JH, Pedula KL, Cauley JA, et al. Evaluating the value of repeat bone mineral density measurement and prediction of fractures in older women: the study of osteoporotic fractures. Arch Intern Med. 2007;167(2):155–60.

    Article  PubMed  Google Scholar 

  10. Berger C, Langsetmo L, Joseph L, Hanley DA, Davison KS, Josse RG, et al. Association between change in BMD and fragility fracture in women and men. J Bone Miner Res. 2009;24(2):361–70.

    Article  PubMed  Google Scholar 

  11. Nguyen TV, Center JR, Eisman JA. Femoral neck bone loss predicts fracture risk independent of baseline BMD. J Bone Miner Res. 2005;20(7):1195–201.

    Article  PubMed  Google Scholar 

  12. Meunier PJ, Roux C, Seeman E, Ortolani S, Badurski JE, Spector TD, et al. The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med. 2004;350(5):459–68.

    Article  CAS  PubMed  Google Scholar 

  13. Reginster JY, Seeman E, De Vernejoul MC, Adami S, Compston J, Phenekos C, et al. Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: treatment of Peripheral Osteoporosis (TROPOS) study. J Clin Endocrinol Metab. 2005;90(5):2816–22.

    Article  CAS  PubMed  Google Scholar 

  14. Slosman D, Provvedini DM, Meunier PJ, Delmas PD, Sebert JL, De Vernejoul MC, et al. The use of different dual X-ray absorptiometry brands in a multicenter clinical trial. J Clin Densitom. 1999;2(1):37–44.

    Article  Google Scholar 

  15. Genant HK, Wu CY, van Kuijk C, Nevitt MC. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res. 1993;8(9):1137–48.

    Article  CAS  PubMed  Google Scholar 

  16. Liu G, Peacock M, Eilam O, Dorulla G, Braunstein E, Johnston CC. Effect of osteoarthritis in the lumbar spine and hip on bone mineral density and diagnosis of osteoporosis in elderly men and women. Osteoporos Int. 1997;7(6):564–9.

    Article  CAS  PubMed  Google Scholar 

  17. Kleerekoper M, Villanueva AR, Stanciu J, Rao DS, Parfitt AM. The role of three-dimensional trabecular microstructure in the pathogenesis of vertebral compression fractures. Calcif Tissue Int. 1985;37(6):594–7.

    Article  CAS  PubMed  Google Scholar 

  18. Legrand E, Chappard D, Pascaretti C, Duquenne M, Krebs S, Rohmer V, et al. Trabecular bone microarchitecture, bone mineral density, and vertebral fractures in male osteoporosis. J Bone Miner Res. 2000;15(1):13–9.

    Article  CAS  PubMed  Google Scholar 

  19. Sambrook PN, Chen CJ, March L, Cameron ID, Cumming RG, Lord SR, et al. High bone turnover is an independent predictor of mortality in the frail elderly. J Bone Miner Res. 2006;21(4):549–55.

    Article  PubMed  Google Scholar 

  20. Chen P, Miller PD, Delmas PD, Misurski DA, Krege JH. Change in lumbar spine BMD and vertebral fracture risk reduction in teriparatide-treated postmenopausal women with osteoporosis. J Bone Miner Res. 2006;21(11):1785–90.

    Article  CAS  PubMed  Google Scholar 

  21. Cummings SR, Karpf DB, Harris F, Genant HK, Ensrud K, LaCroix AZ, et al. Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs. Am J Med. 2002;112(4):281–9.

    Article  CAS  PubMed  Google Scholar 

  22. Delmas PD, Seeman E. Changes in bone mineral density explain little of the reduction in vertebral or nonvertebral fracture risk with anti-resorptive therapy. Bone. 2004;34(4):599–604.

    Article  CAS  PubMed  Google Scholar 

  23. Hochberg MC, Greenspan S, Wasnich RD, Miller P, Thompson DE, Ross PD. Changes in bone density and turnover explain the reductions in incidence of nonvertebral fractures that occur during treatment with antiresorptive agents. J Clin Endocrinol Metab. 2002;87(4):1586–92.

    Article  CAS  PubMed  Google Scholar 

  24. Hochberg MC, Ross PD, Black D, Cummings SR, Genant HK, Nevitt MC, et al. Larger increases in bone mineral density during alendronate therapy are associated with a lower risk of new vertebral fractures in women with postmenopausal osteoporosis. Fracture Intervention Trial Research Group. Arthritis Rheum. 1999;42(6):1246–54.

    Article  CAS  PubMed  Google Scholar 

  25. Li Z, Meredith MP, Hoseyni MS. A method to assess the proportion of treatment effect explained by a surrogate endpoint. Stat Med. 2001;20(21):3175–88.

    Article  CAS  PubMed  Google Scholar 

  26. Sarkar S, Mitlak BH, Wong M, Stock JL, Black DM, Harper KD. Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy. J Bone Miner Res. 2002;17(1):1–10.

    Article  CAS  PubMed  Google Scholar 

  27. Wasnich RD, Miller PD. Antifracture efficacy of antiresorptive agents are related to changes in bone density. J Clin Endocrinol Metab. 2000;85(1):231–6.

    Article  CAS  PubMed  Google Scholar 

  28. Bruyere O, Roux C, Detilleux J, Slosman DO, Spector TD, Fardellone P, et al. Relationship between bone mineral density changes and fracture risk reduction in patients treated with strontium ranelate. J Clin Endocrinol Metab. 2007;92(8):3076–81.

    Article  CAS  PubMed  Google Scholar 

  29. Bruyere O, Roux C, Badurski J, Isaia G, de Vernejoul MC, Cannata J, et al. Relationship between change in femoral neck bone mineral density and hip fracture incidence during treatment with strontium ranelate. Curr Med Res Opin. 2007;23(12):3041–5.

    Article  CAS  PubMed  Google Scholar 

  30. Rizzoli R, Boonen S, Brandi ML, Burlet N, Delmas P, Reginster JY. The role of calcium and vitamin D in the management of osteoporosis. Bone. 2008;42(2):246–9.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study has been supported by a research grant from Servier. However, Servier had no control in study design, data collection and analysis, interpretation of data, in the writing of the report and in the decision to submit the paper for publication.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Olivier Bruyere.

Additional information

Parts of these data have been accepted, as oral communications, at the annual congress of the European League Against Rheumatism (Paris, France, 2008) and at the European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (Istanbul, Turkey, 2008).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bruyere, O., Varela, A.R., Adami, S. et al. Loss of hip bone mineral density over time is associated with spine and hip fracture incidence in osteoporotic postmenopausal women. Eur J Epidemiol 24, 707–712 (2009). https://doi.org/10.1007/s10654-009-9381-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10654-009-9381-4

Keywords

Navigation